# the Effect of Formulation on Anxiety in Autist Childre A Randomized Controlled Trial Assesses Spirulina Syrup Plus Risperidone in Children With Non-idiopathic Autism. Anxiety is Measured Using the SCAS (Parent Version) Via Daily Online Surveys for One Week and Throughout a 3-month Follow-up Period.

> **NCT07060872** · NA · NOT_YET_RECRUITING · sponsor: **Shahid Sadoughi University of Medical Sciences and Health Services** · enrollment: 82 (estimated)

## Conditions studied

- Age 3 to 7 Years
- Mild Autism Spectrum
- no Other Illness or Disorder

## Interventions

- **DIETARY_SUPPLEMENT:** Spirulina Syrup
- **DIETARY_SUPPLEMENT:** Placebo Syrup
- **DRUG:** Risperidone

## Key facts

- **NCT ID:** NCT07060872
- **Lead sponsor:** Shahid Sadoughi University of Medical Sciences and Health Services
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-07
- **Primary completion:** 2025-09-15
- **Final completion:** 2025-10-01
- **Target enrollment:** 82 (ESTIMATED)
- **Last updated:** 2025-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07060872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07060872, "the Effect of Formulation on Anxiety in Autist Childre A Randomized Controlled Trial Assesses Spirulina Syrup Plus Risperidone in Children With Non-idiopathic Autism. Anxiety is Measured Using the SCAS (Parent Version) Via Daily Online Surveys for One Week and Throughout a 3-month Follow-up Period.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07060872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*